1-61082806-CTG-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_001134673.4(NFIA):c.17_18delGT(p.Cys6fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (no stars). Synonymous variant affecting the same amino acid position (i.e. C6C) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 28)
Consequence
NFIA
NM_001134673.4 frameshift
NM_001134673.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.63
Genes affected
NFIA (HGNC:7784): (nuclear factor I A) This gene encodes a member of the NF1 (nuclear factor 1) family of transcription factors. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 38 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-61082806-CTG-C is Pathogenic according to our data. Variant chr1-61082806-CTG-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3344300.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFIA | NM_001134673.4 | c.17_18delGT | p.Cys6fs | frameshift_variant | 1/11 | ENST00000403491.8 | NP_001128145.1 | |
NFIA | NM_001145512.2 | c.152_153delGT | p.Cys51fs | frameshift_variant | 2/12 | NP_001138984.1 | ||
NFIA | NM_005595.5 | c.17_18delGT | p.Cys6fs | frameshift_variant | 1/10 | NP_005586.1 | ||
NFIA | NM_001145511.2 | c.3+5180_3+5181delGT | intron_variant | NP_001138983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFIA | ENST00000403491.8 | c.17_18delGT | p.Cys6fs | frameshift_variant | 1/11 | 1 | NM_001134673.4 | ENSP00000384523.3 |
Frequencies
GnomAD3 genomes Cov.: 28
GnomAD3 genomes
Cov.:
28
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 28
GnomAD4 genome
Cov.:
28
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
NFIA-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 25, 2024 | The NFIA c.17_18delGT variant is predicted to result in a frameshift and premature protein termination (p.Cys6Serfs*5). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. Frameshift variants in NFIA are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.